期刊文献+

在全身热化疗术中长托宁与东莨菪碱联合应用的临床研究 被引量:1

The clinical research of penehyclidine hydrochloride injection combined with scopolamine in the whole body hyperthermia
下载PDF
导出
摘要 目的探讨全身热化疗术中长托宁与东莨菪碱联合应用的临床可行性。方法选择30例ASAⅠ~Ⅱ级患者,分为长托宁与东莨菪碱联合应用组(A组)、长托宁组(B组)、东莨菪碱组(C组),关舱前A组和B组肌注长托宁0.02mg/kg,C组肌注东莨菪碱0.01mg/kg,术中根据出汗情况A组和C组追加东莨菪碱、B组追加长托宁,观察三组患者的食管温度升至41.8℃所需要的时间,升温前、升温至39℃、40℃、41.8℃、维持41.8℃2h的HR、MAP、CVP及术后不良反应的发生率。结果 A组和B组患者食管温度升至41.8℃所需要的时间相比无统计学差异,A、B组与C组相比的升温时间明显缩短(P<0.05);A组在40℃、41.8℃、维持41.8℃2h时的HR与B组相比均增快,但无统计学意义,C组在各温度点的HR与A组、B组相比均明显增快(P<0.05);当食管温度达到40℃以上,患者的MAP随着心率增快而下降,CVP随着心率的增快而升高,C组与A组、B组相比,MAP明显下降(P<0.05),CVP明显增高(P<0.05);B组和A组、C组相比术后的不良反应明显增加(P<0.01)。结论在全身热化疗术中长托宁与东莨菪碱联合应用能明显缩短升温时间,维持循环动力学的稳定,并减少不良反应的发生。 Objective To investigate the clinical validity of penehyclidine hydrochloride injection combined with scopolamine in the whole body hyperthermia(WBH).Methods 30 patients,ASA Ⅰ-Ⅱ,were randomly divided into three groups: A,B and C group.The patients in A group(n=10) and B group(n=10) intramuscularly injected with penehyclidine hydrochloride(0.02mg/kg) before closing the infrared cabin.C group(n=10) intramuscularly injected with scopolamine(0.01mg/kg) at the same time.If patient had obvious sweat during WBH,additional scopolamine were injected in A and C group,and penehyclidine hydrochloride in B group.Record the time during the esophageal temperature increased to 41.8 ℃.The HR,MAP,CVP and incidence of adverse effect were recorded respectively at the time of pre-heating,heating to 39 ℃,40℃,41.8℃,and keeping body temperature at 41.8℃ for 2 hour.Results The time heating to 41.8℃ in A group had no significant different with that in the B group(P0.05).Compared with C group,A and B group had significant shorter heating time(P0.05).Although the HR in A group were faster than that in B group at the time of heating to 40℃,41.8℃ and keeping body temperature at 41.8℃ for 2 hour,there were no significant difference.The HR in C group at each time were all faster than HR in A and B groups(P0.05).After the esophageal temperature increased to 40 ℃,the MAP decreased along with the HR increase,and the CVP increased.Compared with A and B group,the MAP in C group were significantly decreased,and the CVP were increased.The incidence of adverse effects in B group were significantly increased(P0.01).Conclusion Penehyclidine hydrochloride injection combined with scopolamine in WBH can significantly decrease the heating time,keep haemodynamics stability and decrease the incidence of adverse reaction.
出处 《西部医学》 2012年第1期83-85,共3页 Medical Journal of West China
关键词 全身热疗 长托宁 东莨菪碱 血流动力学 Whole body hyperthermia Penehyclidine hydrochloride Scopolamine Haemodynamics
  • 相关文献

参考文献10

  • 1李立军主编.现代高新技术治疗恶性肿瘤[M].北京:人民军医出版社,2003,275-277.
  • 2Masunaga S,Ono K,Takahashi A,et al. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53Status[J]. Cancer Sci, 2003,94(1): 125-133.
  • 3Morita M, Kuwano H, Araki K, et al. Prognostic significance of Lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer[J]. Int J Ra-Diat Oncol Biol Phys,2001,49(5):1259-1266.
  • 4Mohamed F,Marehettini P, Stuart OA, et al. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia [J]. Arin surg Oncol, 2003,10 (4) : 463-468.
  • 5Nakao K,Otsuki Y,Akao Y,et al. The synergistic effects of Hyperthermia and anticancer drugs on induction of apoptosts[J]. Med Electron Mierosc,2000,33(1): 44-50.
  • 6牛文忠,高占国,赵德禄,刘传缋.3-(2-羟基-2-环戊基-2-苯基-乙氧基)奎宁环烷及其光学异构体与外周毒蕈碱性受体的结合特性(英文)[J].中国药理学与毒理学杂志,1999,13(1):5-8. 被引量:64
  • 7Kemer T, Dia, Ahl.ers O, et al. Whole body hypertherma: a secure procedure for patients with various malignancies[J]. In- Tensive Care Med, 1999,25,959.
  • 8肖美英,宋建顺,章岳山,黄传继,李鼎九.大功率微波区域/全身低热对心血管某些功能的影响[J].齐鲁肿瘤杂志,1999,6(1):6-7. 被引量:7
  • 9Robins HI, Hugander A, Cohen JD, et al. Whole body hyperther- Mia in the treatment of neoplase diseade [J]. Radiol Clin Nor-Th Am,1989,27(3) :603.
  • 10Vertrees RT, Bidani A, Donald Jet al. Venovenous perfusion- induced systermic hyperthermia hemodynamics, blood flow: and thermal gradients[J]. Ann thorae surg, 2000,70 (2), 644-652.

二级参考文献6

  • 1文广伶 李叔埙 等.2,2,2-苯基羟基取代基乙基(环烃胺基)醚类化合物的合成[J].军事医学科学院院刊,1985,9(6):613-617.
  • 2Niu W Z,Arch Int Pharmacodyn Ther,1990年,304卷,1期,64页
  • 3文广伶,军事医学科学院院刊,1985年,9卷,6期,613页
  • 4Cheng Y C,Biochem Pharmacol,1973年,22卷,23期,3099页
  • 5Gao Z G,Eur J Pharmacol,1995年,289卷,2期,369页
  • 6Gao Z G,Life Sci,1995年,56卷,25期,L461页

共引文献79

同被引文献5

  • 1李立军主编.现代高新技术治疗恶性肿瘤[M].北京:人民军医出版社,2003,275-277.
  • 2王明安,王明德.麻醉后恢复期患者的评估与治疗[M].北京:人民卫生出版社,2002:90-91.
  • 3郭俊召,刘文超,陈衍,等.全身热疗联合化疗治疗晚期恶性肿瘤-220例疗效分析[J].现代肿瘤学杂志,2012,20(11):2389—2393.
  • 4HURFORD W E. Critical care Handbook of the Massachuretta Ge- beral Hospital[ M]..3版,沈阳:辽宁科学技术出版社,200l:81—82.
  • 5马永全,杜芳,王辉,王庆康.193例恶性肿瘤患者全身热化疗不良反应分析[J].实用医药杂志,2010,27(3):196-198. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部